Jaschinski, Frank <br/><br/>
The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-β2.  [electronic resource] 

 -  Current pharmaceutical biotechnology  Dec 2011 
 - 2203-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-4316 
<br/><br/><label>Standard No.: </label>10.2174/138920111798808266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Humans<br/>Neoplasms--drug therapy<br/>Oligodeoxyribonucleotides--therapeutic use<br/>Thionucleotides--therapeutic use<br/>Transforming Growth Factor beta2--antagonists & inhibitors